An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer (Q43880102)

27 November 2017

title

An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer (English)

1 reference

27 November 2017

8

Valerie W Rusch

1 reference

27 November 2017

9

Steven M Larson

1 reference

27 November 2017

Tim Akhurst

1

1 reference

27 November 2017

Robert J Downey

2

1 reference

27 November 2017

Michelle S Ginsberg

3

1 reference

27 November 2017

Mithat Gonen

4

1 reference

27 November 2017

Manjit Bains

5

1 reference

27 November 2017

Robert Korst

6

1 reference

27 November 2017

Robert J Ginsberg

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

The Annals of Thoracic Surgery

27 November 2017

published in

1 reference

27 November 2017

volume

73

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

259-64; discussion 264-6

1 reference

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Primary tumors and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: serial CT findings with pathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

7 January 2021

Repeat mediastinoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Repeat mediastinoscopy in the staging of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Remediastinoscopy after induction chemotherapy in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

Revisions in the International System for Staging Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2903257-X

10.1016/S0003-4975(01)03257-X

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference